/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | NUTXNutex Health Inc. |
|---|---|
| Last close | $194.16close 2026-11-09 |
| Change % | +7.53%close 2026-11-09 |
| Market cap | $1.3Bclose 2026-11-09 |
| P/E | 18.5FY to 2025-12-31 |
| Revenue | $875M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2025-12-31 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 82.4%FY to 2025-12-31 |
| Net income | $71M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-015168 · filed 2026-03-05 Open the filing on EDGAR →Open the XBRL payload →CiteNutex Health Inc. (NUTX), us-gaap:NetIncomeLoss: 70,789,000 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001628280-26-015168, filed 2026-03-05. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001479681/us-gaap/NetIncomeLoss.json |
| Net margin | 8.1%FY to 2025-12-31 |
| EPS (diluted) | $10.48⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-015168 · filed 2026-03-05 Open the filing on EDGAR →Open the XBRL payload →CiteNutex Health Inc. (NUTX), us-gaap:EarningsPerShareDiluted: 10.48 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001628280-26-015168, filed 2026-03-05. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001479681/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 7FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | 3.62FY to 2025-12-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | 02-27 → 03-09 |